Ligand Pharmaceuticals Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2015-09-30 3 months ending 2015-06-30 3 months ending 2015-03-31 3 months ending 2014-12-31 3 months ending 2014-09-30
Revenue 17.70 18.42 14.60 23.00 14.97
Other Revenue, Total - - - - -
Total Revenue 17.70 18.42 14.60 23.00 14.97
Cost of Revenue, Total 1.25 2.60 1.07 4.00 1.50
Gross Profit 16.45 15.82 13.53 19.00 13.48
Selling/General/Admin. Expenses, Total 4.97 7.22 5.99 5.52 6.74
Research & Development 2.54 4.01 3.96 3.28 3.02
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.34 -27.97 0.22 0.56 0.18
Other Operating Expenses, Total - - - - -
Total Operating Expense 9.10 -14.14 11.25 13.36 11.44
Operating Income 8.60 32.55 3.35 9.64 3.53
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net 3.79 -6.42 -0.45 0.29 -1.11
Income Before Tax 7.28 22.29 -0.07 7.01 0.90
Income After Tax 224.54 22.03 -0.09 6.73 0.78
Minority Interest 0.00 1.54 0.84 0.32 0.50
Equity In Affiliates - - - - -
Net Income Before Extra. Items 224.54 23.56 0.75 7.05 1.28
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 224.54 23.56 0.75 7.05 1.28
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 224.54 23.56 0.75 7.05 1.28
Income Available to Common Incl. Extra Items 224.54 23.56 0.75 7.05 1.28
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - - -
Diluted Weighted Average Shares 21.46 21.28 20.63 20.84 21.35
Diluted EPS Excluding Extraordinary Items 10.46 1.11 0.04 0.34 0.06
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 - 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 10.47 0.25 0.04 0.36 0.07